NCT03532971View on ClinicalTrials.gov

Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 30, 2018

Primary Completion Date

September 14, 2020

Study Completion Date

September 14, 2020

Conditions
BK Virus Infection
Interventions
OTHER

Symptom index questionnaire

A survey administered to identify the symptoms of the patient

DIAGNOSTIC_TEST

BK polyomavirus PCR

quantitative PCR testing

OTHER

quality of life questionnaires

Standard questionnaires validated for HCT recipients

Trial Locations (1)

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT03532971 - Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes | Biotech Hunter | Biotech Hunter